Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
3
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(4)
Terminated(3)
Other(2)

Detailed Status

Completed4
unknown2
Withdrawn2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
80.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

terminated111%
completed444%
unknown222%
withdrawn222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9